Premium
A physician's approach and experience of managing patients with diabetes during COVID ‐19
Author(s) -
Ruslan Aliya,
Williams David M,
Purnell Oliver,
Edwards Rhodri,
Peter Raj,
Stephens Jeffrey W,
Chudleigh Richard
Publication year - 2021
Publication title -
practical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.205
H-Index - 24
eISSN - 2047-2900
pISSN - 2047-2897
DOI - 10.1002/pdi.2329
Subject(s) - medicine , diabetes mellitus , pandemic , intensive care medicine , covid-19 , vulnerability (computing) , type 2 diabetes , population , diabetes management , gerontology , disease , endocrinology , environmental health , infectious disease (medical specialty) , computer security , computer science
Since the start of the COVID‐19 pandemic, the vulnerability of people with diabetes has been recognised with a greater risk of morbidity and mortality compared to the general population. The outcomes associated with diabetes may be a consequence of an impaired immune response, presence of composite comorbidities or the multi‐organ infectivity of SARS‐CoV‐2 affecting the pancreas. Emerging evidence suggests that both acute and chronic hyperglycaemia can exacerbate the clinical consequences of COVID‐19. Thus, the role of health care professionals in the observation and management of glucose control is increasingly recognised in people with diabetes in both the acute and chronic setting. In this review, we highlight the key biological implications of SARS‐CoV‐2 infection in people with diabetes, the clinical outcomes of COVID‐19 in people with diabetes and management principles with respect to glucose control including our local experiences. Copyright © 2021 John Wiley & Sons.